106 related articles for article (PubMed ID: 23314761)
1. Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound.
El Kaffas A; Giles A; Czarnota GJ
Angiogenesis; 2013 Apr; 16(2):443-54. PubMed ID: 23314761
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy.
El Kaffas A; Sadeghi-Naini A; Falou O; Tran WT; Zhou S; Hashim A; Fernandes J; Giles A; Czarnota GJ
Med Phys; 2015 Aug; 42(8):4965-73. PubMed ID: 26233222
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib effects on the radiation response of endothelial and breast tumor cells.
El Kaffas A; Al-Mahrouki A; Tran WT; Giles A; Czarnota GJ
Microvasc Res; 2014 Mar; 92():1-9. PubMed ID: 24215790
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
6. Effect of sunitinib combined with ionizing radiation on endothelial cells.
Zhang HP; Takayama K; Su B; Jiao XD; Li R; Wang JJ
J Radiat Res; 2011; 52(1):1-8. PubMed ID: 21187670
[TBL] [Abstract][Full Text] [Related]
7. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
Schueneman AJ; Himmelfarb E; Geng L; Tan J; Donnelly E; Mendel D; McMahon G; Hallahan DE
Cancer Res; 2003 Jul; 63(14):4009-16. PubMed ID: 12873999
[TBL] [Abstract][Full Text] [Related]
8. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
9. Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
Shinohara ET; Cao C; Niermann K; Mu Y; Zeng F; Hallahan DE; Lu B
Oncogene; 2005 Aug; 24(35):5414-22. PubMed ID: 15940265
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma.
Yoon SS; Stangenberg L; Lee YJ; Rothrock C; Dreyfuss JM; Baek KH; Waterman PR; Nielsen GP; Weissleder R; Mahmood U; Park PJ; Jacks T; Dodd RD; Fisher CJ; Ryeom S; Kirsch DG
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1207-16. PubMed ID: 19545786
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model.
Tanaka Y; Shibata MA; Morimoto J; Otsuki Y
Anticancer Res; 2011 Apr; 31(4):1225-34. PubMed ID: 21508369
[TBL] [Abstract][Full Text] [Related]
12. SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice.
Laird AD; Christensen JG; Li G; Carver J; Smith K; Xin X; Moss KG; Louie SG; Mendel DB; Cherrington JM
FASEB J; 2002 May; 16(7):681-90. PubMed ID: 11978732
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.
Sonpavde G; Jian W; Liu H; Wu MF; Shen SS; Lerner SP
Urol Oncol; 2009; 27(4):391-9. PubMed ID: 18534874
[TBL] [Abstract][Full Text] [Related]
14. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
Czabanka M; Vinci M; Heppner F; Ullrich A; Vajkoczy P
Int J Cancer; 2009 Mar; 124(6):1293-300. PubMed ID: 19101989
[TBL] [Abstract][Full Text] [Related]
15. Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment.
Palmowski M; Huppert J; Hauff P; Reinhardt M; Schreiner K; Socher MA; Hallscheidt P; Kauffmann GW; Semmler W; Kiessling F
Cancer Res; 2008 Sep; 68(17):7042-9. PubMed ID: 18757418
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
Koo HJ; Lee M; Kim J; Woo CW; Jeong SY; Choi EK; Kim N; Lee JS
PLoS One; 2016; 11(2):e0148784. PubMed ID: 26862906
[TBL] [Abstract][Full Text] [Related]
17. Tumour Vascular Shutdown and Cell Death Following Ultrasound-Microbubble Enhanced Radiation Therapy.
El Kaffas A; Gangeh MJ; Farhat G; Tran WT; Hashim A; Giles A; Czarnota GJ
Theranostics; 2018; 8(2):314-327. PubMed ID: 29290810
[TBL] [Abstract][Full Text] [Related]
18. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib malate for the treatment of renal cell carcinoma.
Wood L
Expert Opin Pharmacother; 2012 Jun; 13(9):1323-36. PubMed ID: 22607009
[TBL] [Abstract][Full Text] [Related]
20. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors.
Shojaei F; Lee JH; Simmons BH; Wong A; Esparza CO; Plumlee PA; Feng J; Stewart AE; Hu-Lowe DD; Christensen JG
Cancer Res; 2010 Dec; 70(24):10090-100. PubMed ID: 20952508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
